Human Gene FZD4 (ENST00000531380.2_7) from GENCODE V47lift37
  Description: frizzled class receptor 4 (from RefSeq NM_012193.4)
Gencode Transcript: ENST00000531380.2_7
Gencode Gene: ENSG00000174804.4_9
Transcript (Including UTRs)
   Position: hg19 chr11:86,656,721-86,666,437 Size: 9,717 Total Exon Count: 2 Strand: -
Coding Region
   Position: hg19 chr11:86,662,184-86,666,127 Size: 3,944 Coding Exon Count: 2 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr11:86,656,721-86,666,437)mRNA (may differ from genome)Protein (537 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedReactome
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: FZD4_HUMAN
DESCRIPTION: RecName: Full=Frizzled-4; Short=Fz-4; Short=hFz4; AltName: Full=FzE4; AltName: CD_antigen=CD344; Flags: Precursor;
FUNCTION: Receptor for Wnt proteins. Most of frizzled receptors are coupled to the beta-catenin (CTNNB1) canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin (CTNNB1) and activation of Wnt target genes. Plays a critical role in retinal vascularization by acting as a receptor for Wnt proteins and norrin (NDP). In retina, it can be both activated by Wnt protein-binding, but also by a Wnt-independent signaling via binding of norrin (NDP), promoting in both cases beta-catenin (CTNNB1) accumulation and stimulation of LEF/TCF-mediated transcriptional programs. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues.
SUBUNIT: Interacts with MAGI3 and norrin (NDP). Component of a complex, at least composed of TSPAN12, FZD4 and norrin (NDP) (By similarity).
INTERACTION: G3GTH2:I79_000956 (xeno); NbExp=2; IntAct=EBI-2466380, EBI-3504975;
SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein (By similarity).
TISSUE SPECIFICITY: Almost ubiquitous. Largely expressed in adult heart, skeletal muscle, ovary, and fetal kidney. Moderate amounts in adult liver, kidney, pancreas, spleen, and fetal lung, and small amounts in placenta, adult lung, prostate, testis, colon, fetal brain and liver.
DOMAIN: Lys-Thr-X-X-X-Trp motif interacts with the PDZ doman of Dvl (Disheveled) family members and is involved in the activation of the Wnt/beta-catenin signaling pathway (By similarity).
DOMAIN: The FZ domain is involved in binding with Wnt ligands (By similarity).
PTM: Ubiquitinated by ZNRF3, leading to its degradation by the proteasome.
DISEASE: Defects in FZD4 are the cause of vitreoretinopathy exudative type 1 (EVR1) [MIM:133780]; also known as autosomal dominant familial exudative vitreoretinopathy (FEVR) or Criswick- Schepens syndrome. EVR1 is a disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease-related abnormality is an arc of avascular retina in the extreme temporal periphery.
SIMILARITY: Belongs to the G-protein coupled receptor Fz/Smo family.
SIMILARITY: Contains 1 FZ (frizzled) domain.
WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/FZD4";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: FZD4
Diseases sorted by gene-association score: exudative vitreoretinopathy 1* (1450), exudative vitreoretinopathy* (629), coats disease* (424), persistent hyperplastic primary vitreous* (258), fzd4-related familial exudative vitreoretinopathy, autosomal dominant* (100), retinal detachment (22), leukocoria (17), norrie disease (10), osteoporosis-pseudoglioma syndrome (9), usher syndrome, type ik (9), retinal telangiectasia (8), deafness, autosomal recessive 33 (7), retinal vascular disease (6), eye degenerative disease (6), colorectal cancer (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 20.42 RPKM in Adipose - Subcutaneous
Total median expression: 169.68 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -156.00310-0.503 Picture PostScript Text
3' UTR -1637.805463-0.300 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR000539 - Frizzled
IPR015526 - Frizzled/SFRP
IPR020067 - Frizzled_dom
IPR026551 - FZD4
IPR017981 - GPCR_2-like

Pfam Domains:
PF01392 - Fz domain
PF01534 - Frizzled/Smoothened family membrane region

SCOP Domains:
63501 - Frizzled cysteine-rich domain

ModBase Predicted Comparative 3D Structure on Q9ULV1
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGDEnsembl   
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0001540 beta-amyloid binding
GO:0004871 signal transducer activity
GO:0004888 transmembrane signaling receptor activity
GO:0004930 G-protein coupled receptor activity
GO:0005515 protein binding
GO:0017147 Wnt-protein binding
GO:0019955 cytokine binding
GO:0030165 PDZ domain binding
GO:0031625 ubiquitin protein ligase binding
GO:0038023 signaling receptor activity
GO:0042803 protein homodimerization activity
GO:0042813 Wnt-activated receptor activity
GO:0046982 protein heterodimerization activity

Biological Process:
GO:0001553 luteinization
GO:0001568 blood vessel development
GO:0001570 vasculogenesis
GO:0007165 signal transduction
GO:0007166 cell surface receptor signaling pathway
GO:0007186 G-protein coupled receptor signaling pathway
GO:0007223 Wnt signaling pathway, calcium modulating pathway
GO:0007275 multicellular organism development
GO:0007605 sensory perception of sound
GO:0010812 negative regulation of cell-substrate adhesion
GO:0016055 Wnt signaling pathway
GO:0030182 neuron differentiation
GO:0030947 regulation of vascular endothelial growth factor receptor signaling pathway
GO:0031987 locomotion involved in locomotory behavior
GO:0034446 substrate adhesion-dependent cell spreading
GO:0035426 extracellular matrix-cell signaling
GO:0035567 non-canonical Wnt signaling pathway
GO:0042701 progesterone secretion
GO:0043507 positive regulation of JUN kinase activity
GO:0045893 positive regulation of transcription, DNA-templated
GO:0051091 positive regulation of sequence-specific DNA binding transcription factor activity
GO:0060070 canonical Wnt signaling pathway
GO:0060071 Wnt signaling pathway, planar cell polarity pathway
GO:0061024 membrane organization
GO:0061299 retina vasculature morphogenesis in camera-type eye
GO:0061301 cerebellum vasculature morphogenesis
GO:0061304 retinal blood vessel morphogenesis
GO:0071300 cellular response to retinoic acid
GO:1990830 cellular response to leukemia inhibitory factor

Cellular Component:
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0005911 cell-cell junction
GO:0009986 cell surface
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0030425 dendrite
GO:0030665 clathrin-coated vesicle membrane
GO:0030669 clathrin-coated endocytic vesicle membrane


-  Descriptions from all associated GenBank mRNAs
  KJ892495 - Synthetic construct Homo sapiens clone ccsbBroadEn_01889 FZD4 gene, encodes complete protein.
KR711882 - Synthetic construct Homo sapiens clone CCSBHm_00031692 FZD4 (FZD4) mRNA, encodes complete protein.
KR711883 - Synthetic construct Homo sapiens clone CCSBHm_00031699 FZD4 (FZD4) mRNA, encodes complete protein.
KR711884 - Synthetic construct Homo sapiens clone CCSBHm_00031701 FZD4 (FZD4) mRNA, encodes complete protein.
AK025791 - Homo sapiens cDNA: FLJ22138 fis, clone HEP20956, highly similar to AB032417 Homo sapiens FZD4 mRNA for WNT receptor Frizzled-4.
AB032417 - Homo sapiens FZD4 mRNA for WNT receptor Frizzled-4, complete cds.
AK025516 - Homo sapiens cDNA: FLJ21863 fis, clone HEP02322, highly similar to AB032417 Homo sapiens FZD4 mRNA for WNT receptor Frizzled-4.
JD284733 - Sequence 265757 from Patent EP1572962.
JD410407 - Sequence 391431 from Patent EP1572962.
JD118623 - Sequence 99647 from Patent EP1572962.
JD227013 - Sequence 208037 from Patent EP1572962.
JD202126 - Sequence 183150 from Patent EP1572962.
JD084568 - Sequence 65592 from Patent EP1572962.
JD389273 - Sequence 370297 from Patent EP1572962.
JD263948 - Sequence 244972 from Patent EP1572962.
JD367034 - Sequence 348058 from Patent EP1572962.
JD082890 - Sequence 63914 from Patent EP1572962.
JD363109 - Sequence 344133 from Patent EP1572962.
JD355212 - Sequence 336236 from Patent EP1572962.
JD051214 - Sequence 32238 from Patent EP1572962.
JD504486 - Sequence 485510 from Patent EP1572962.
JD058819 - Sequence 39843 from Patent EP1572962.
JD072062 - Sequence 53086 from Patent EP1572962.
JD281484 - Sequence 262508 from Patent EP1572962.
JD160920 - Sequence 141944 from Patent EP1572962.
JD153074 - Sequence 134098 from Patent EP1572962.
JD198364 - Sequence 179388 from Patent EP1572962.
JD272019 - Sequence 253043 from Patent EP1572962.
JD552159 - Sequence 533183 from Patent EP1572962.
JD221410 - Sequence 202434 from Patent EP1572962.
JD171291 - Sequence 152315 from Patent EP1572962.
JD513798 - Sequence 494822 from Patent EP1572962.
JD228261 - Sequence 209285 from Patent EP1572962.
JD449905 - Sequence 430929 from Patent EP1572962.
JD314578 - Sequence 295602 from Patent EP1572962.
JD299514 - Sequence 280538 from Patent EP1572962.
JD433038 - Sequence 414062 from Patent EP1572962.
JD534919 - Sequence 515943 from Patent EP1572962.
JD449591 - Sequence 430615 from Patent EP1572962.
JD260269 - Sequence 241293 from Patent EP1572962.
JD553229 - Sequence 534253 from Patent EP1572962.
JD268287 - Sequence 249311 from Patent EP1572962.
JD507834 - Sequence 488858 from Patent EP1572962.
JD091144 - Sequence 72168 from Patent EP1572962.
JD333516 - Sequence 314540 from Patent EP1572962.
JD132266 - Sequence 113290 from Patent EP1572962.
JD056572 - Sequence 37596 from Patent EP1572962.
JD226058 - Sequence 207082 from Patent EP1572962.
JD456557 - Sequence 437581 from Patent EP1572962.
JD111907 - Sequence 92931 from Patent EP1572962.
JD183612 - Sequence 164636 from Patent EP1572962.
JD207846 - Sequence 188870 from Patent EP1572962.
JD053810 - Sequence 34834 from Patent EP1572962.
JD549030 - Sequence 530054 from Patent EP1572962.
JD232895 - Sequence 213919 from Patent EP1572962.
JD283855 - Sequence 264879 from Patent EP1572962.
JD427778 - Sequence 408802 from Patent EP1572962.
JD136975 - Sequence 117999 from Patent EP1572962.
JD555961 - Sequence 536985 from Patent EP1572962.
JD164216 - Sequence 145240 from Patent EP1572962.
JD261384 - Sequence 242408 from Patent EP1572962.
JD153967 - Sequence 134991 from Patent EP1572962.
JD287545 - Sequence 268569 from Patent EP1572962.
JD122651 - Sequence 103675 from Patent EP1572962.
JD061344 - Sequence 42368 from Patent EP1572962.
JD261447 - Sequence 242471 from Patent EP1572962.
JD060960 - Sequence 41984 from Patent EP1572962.
JD320095 - Sequence 301119 from Patent EP1572962.
JD347782 - Sequence 328806 from Patent EP1572962.
BC114527 - Homo sapiens frizzled homolog 4 (Drosophila), mRNA (cDNA clone MGC:138776 IMAGE:40082087), complete cds.
BC114622 - Homo sapiens frizzled homolog 4 (Drosophila), mRNA (cDNA clone MGC:138777 IMAGE:40082091), complete cds.
JD145775 - Sequence 126799 from Patent EP1572962.
JD370831 - Sequence 351855 from Patent EP1572962.
JD206465 - Sequence 187489 from Patent EP1572962.
JD261253 - Sequence 242277 from Patent EP1572962.
JD416837 - Sequence 397861 from Patent EP1572962.
JD293767 - Sequence 274791 from Patent EP1572962.
JD078570 - Sequence 59594 from Patent EP1572962.
JD390973 - Sequence 371997 from Patent EP1572962.
JD214133 - Sequence 195157 from Patent EP1572962.
JD539384 - Sequence 520408 from Patent EP1572962.
JD244319 - Sequence 225343 from Patent EP1572962.
JD053320 - Sequence 34344 from Patent EP1572962.
JD264106 - Sequence 245130 from Patent EP1572962.
JD235858 - Sequence 216882 from Patent EP1572962.
JD297463 - Sequence 278487 from Patent EP1572962.
JD110255 - Sequence 91279 from Patent EP1572962.
JD041702 - Sequence 22726 from Patent EP1572962.
JD428786 - Sequence 409810 from Patent EP1572962.
JD502908 - Sequence 483932 from Patent EP1572962.
JD363527 - Sequence 344551 from Patent EP1572962.
JD261628 - Sequence 242652 from Patent EP1572962.
JD306197 - Sequence 287221 from Patent EP1572962.
JD548367 - Sequence 529391 from Patent EP1572962.
JD202763 - Sequence 183787 from Patent EP1572962.
JD300004 - Sequence 281028 from Patent EP1572962.
AB054881 - Homo sapiens mRNA for Soluble-type polypeptide FZD4S, complete cds.
JD182726 - Sequence 163750 from Patent EP1572962.
AK292768 - Homo sapiens cDNA FLJ75825 complete cds, highly similar to Homo sapiens frizzled homolog 4 (Drosophila) (FZD4), mRNA.
JD142990 - Sequence 124014 from Patent EP1572962.
JD237575 - Sequence 218599 from Patent EP1572962.
BC025750 - Homo sapiens frizzled homolog 4 (Drosophila), mRNA (cDNA clone IMAGE:5199771), **** WARNING: chimeric clone ****.
JD341504 - Sequence 322528 from Patent EP1572962.
AY462097 - Homo sapiens frizzled 4 (FZD4) mRNA, complete cds.
JD187423 - Sequence 168447 from Patent EP1572962.
JD143206 - Sequence 124230 from Patent EP1572962.
JD519173 - Sequence 500197 from Patent EP1572962.
JD391943 - Sequence 372967 from Patent EP1572962.
JD407236 - Sequence 388260 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein Q9ULV1 (Reactome details) participates in the following event(s):

R-HSA-5099899 WNT5A binds FZD4
R-HSA-5138441 WNT5A-FZD4 recruits DVL2
R-HSA-201708 Frizzled receptors bind Wnts
R-HSA-3965446 WNT5A and WNT11 bind FZD receptors to initiate Ca2+ signaling
R-HSA-5099886 WNT5A binding to FZD promotes PRICKLE1 degradation
R-HSA-5138432 DVL2 is phosphorylated by PKC
R-HSA-5138433 p-DVL2 recruits AP-2 and beta-arrestin 2 to promote clathrin-mediated endocytosis
R-HSA-3965441 FZD recruits trimeric G-proteins
R-HSA-3965447 G-protein subunits dissociate from WNT:FZD complex
R-HSA-4641249 ZNRF3,RNF43 binds the FZD:LRP5/6 receptor complex
R-HSA-4641236 USP8 deubiquitinates FZD to potentiate WNT signaling
R-HSA-4641253 ZNRF3 ubiquitinates FZD to promote its downregulation
R-HSA-8866269 ARRB bind GPCRs
R-HSA-3965444 WNT:FZD complex promotes G-protein nucleotide exchange
R-HSA-8866283 ARBB recruits GPCRs into clathrin-coated pits
R-HSA-8867756 CLASP proteins and cargo are recruited to the nascent clathrin-coated pit
R-HSA-8868071 Clathrin recruits PIK3C2A
R-HSA-8868661 Dynamin-mediated GTP hydrolysis promotes vesicle scission
R-HSA-8868648 SYNJ hydrolyze PI(4,5)P2 to PI(4)P
R-HSA-8871194 RAB5 and GAPVD1 bind AP-2
R-HSA-8868658 HSPA8-mediated ATP hydrolysis promotes vesicle uncoating
R-HSA-8868659 Clathrin recruits auxilins to the clathrin-coated vesicle
R-HSA-8868660 Auxilin recruits HSPA8:ATP to the clathrin-coated vesicle
R-HSA-8867754 F- and N- BAR domain proteins bind the clathrin-coated pit
R-HSA-8868230 SNX9 recruits components of the actin polymerizing machinery
R-HSA-8868072 Clathrin-associated PIK3C2A phosphorylates PI(4)P to PI(3,4)P2
R-HSA-8868236 BAR domain proteins recruit dynamin
R-HSA-8868651 Endophilins recruit synaptojanins to the clathrin-coated pit
R-HSA-5099900 WNT5A-dependent internalization of FZD4
R-HSA-373080 Class B/2 (Secretin family receptors)
R-HSA-4086398 Ca2+ pathway
R-HSA-4608870 Asymmetric localization of PCP proteins
R-HSA-4086400 PCP/CE pathway
R-HSA-500792 GPCR ligand binding
R-HSA-3858494 Beta-catenin independent WNT signaling
R-HSA-4641263 Regulation of FZD by ubiquitination
R-HSA-5340588 RNF mutants show enhanced WNT signaling and proliferation
R-HSA-8856825 Cargo recognition for clathrin-mediated endocytosis
R-HSA-372790 Signaling by GPCR
R-HSA-195721 Signaling by WNT
R-HSA-201681 TCF dependent signaling in response to WNT
R-HSA-4791275 Signaling by WNT in cancer
R-HSA-8856828 Clathrin-mediated endocytosis
R-HSA-162582 Signal Transduction
R-HSA-5663202 Diseases of signal transduction
R-HSA-199991 Membrane Trafficking
R-HSA-1643685 Disease
R-HSA-5653656 Vesicle-mediated transport

-  Other Names for This Gene
  Alternate Gene Symbols: A8K9Q3, ENST00000531380.1, FZD4_HUMAN, NM_012193, Q14C97, Q6S9E4, Q9ULV1, uc324irw.1, uc324irw.2
UCSC ID: ENST00000531380.2_7
RefSeq Accession: NM_012193.4
Protein: Q9ULV1 (aka FZD4_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.